What Next for AEterna Zentaris Inc. Stock After Today’s Huge Decline?

 What Next for AEterna Zentaris Inc. Stock After Today's Huge Decline?

The stock of AEterna Zentaris Inc. (TSE:AEZ) is a huge mover today! About 16,000 shares traded hands. AEterna Zentaris Inc. (TSE:AEZ) has risen 4.08% since April 7, 2016 and is uptrending. It has underperformed by 2.07% the S&P500.
The move comes after 8 months negative chart setup for the $50.38 million company. It was reported on Nov, 11 by Barchart.com. We have $4.27 PT which if reached, will make TSE:AEZ worth $5.54M less.

Aeterna Zentaris Inc. is a specialty biopharmaceutical firm engaged in developing and commercializing treatments in oncology, endocrinology and women’s health. The company has a market cap of $50.38 million. The Firm operates through the biopharmaceutical segment. It currently has negative earnings. The Firm is engaged in drug development activities and in the promotion of products for others.

AEZ.TO Company Profile

Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical firm engaged in developing and commercializing treatments in oncology, endocrinology and women’s health. The Firm operates through the biopharmaceutical segment. The Firm is engaged in drug development activities and in the promotion of products for others. The Company’s principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Firm focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company’s direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment